New heart valve device trial aims to help thousands with severe aortic stenosis
NCT ID NCT07278310
Summary
This trial is testing a new device called the Siegel TAVR System for people with severe, symptomatic aortic stenosis, a serious heart valve condition. The study will enroll over 1,000 adults to see if the device is safe and effective at reducing the risk of death, stroke, and heart-related hospitalizations. The device is implanted via a catheter in the leg, avoiding open-heart surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.